Label Changes for:
Augmentin XR (amoxicillin/clavulanate potassium) Extended Release Tablets
December 2008
Changes have been made to the ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- December 2008
| The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. |
Sections Modified
ADVERSE REACTIONS
- Hypersensitivity Reactions
- hypersensitivity vasculitis
- Liver
- ...hepatitis and cholestatic jaundice, (see CONTRAINDICATIONS)...
